Bill Sponsor
House Bill 4404
116th Congress(2019-2020)
Depression Side Effect Labeling Awareness Act of 2019
Introduced
Introduced
Introduced in House on Sep 19, 2019
Overview
Text
Introduced
Sep 19, 2019
Latest Action
Sep 20, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4404
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Depression Side Effect Labeling Awareness Act of 2019

This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.

Text (1)
September 19, 2019
Actions (3)
09/20/2019
Referred to the Subcommittee on Health.
09/19/2019
Referred to the House Committee on Energy and Commerce.
09/19/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:56 PM